In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with Frances and she starts digging for evidence to support her suspicions. As the pharmaceutical company pushes for speedy approval, Frances discovers the drug's devastating impact. Katie Hafner, host of The Lost Women of Science podcast, joins Tim to explain why America should remember the woman who kept Thalidomide off the market. To join the brand new Cautionary Club and get access to exclusive episodes and ad-free listening, head to patreon.com/cautionaryclub See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.